Soy Oil Extract For Infertility?
Hope Comes from an Obscure Place
Infertility, whether male or female, has devastating effects upon a couple. Treatments can be very taxing at best, especially when they repeatedly fail. It is no surprise that infertility treatments can be more stressful than most other medical problems. There has, though, been some heartening news for women who have endured multiple IVF failures that may make a huge difference.
One of the reasons for failure of IVF procedures is a deficient immune system that rejects a newly implanted embryo and destroys it. In a study completed at Nottingham's Care Fertility clinic, researchers studied the effects of soy oil extract on miscarriage and the findings are very encouraging.
Soy Oil Extract - Who Knew?
Intralipid, is a soy oil extract that is commonly used to feed patients intravenously when they are unable to eat normally as a result of surgery trauma or severe injury. Experts say that women who are apparently in good health suffer recurrent miscarriages and failing IVF treatments because their immune systems are not operating well. Intralipid seems to counter this problem because it runs interference with the immune system's ability to signal an attack on the pregnancy.
Dr. George Ndukwe, Medical Director at Care Fertility clinic said, "Every day in my clinic I see women who have endured numerous IVF cycles all with the same negative outcome and no baby. I also regularly see couples who have suffered the misery of repeated miscarriages. People talk about the financial implications but the emotional one is as bad or, I would say, worse. These women are at the bottom of a dark pit and can't climb out and can't see the light. We are devoting our attention to finding answers when nature goes wrong. This infusion is inexpensive, well tolerated and easy to administer."
The Study's Results
In a research study conducted at the clinic, 100 women at an average age of 37 who had repeated IVF failures were enrolled. 50 women were given intravenous infusions of Intralipid and 46 were not given the soy oil extract. The results showed that half of those treated with Intralipid managed to conceive compared to only 9% of those who were not given Intralipid. Additionally, only two miscarriages occurred in the group treated with soy oil extract as compared to seven in the other group. Finally, 46 percent of women who were administered Intralipid gave birth while only four from the group that did not receive it gave birth.
It appears Intralipid may successfully cut the risk of miscarriage and enhance pregnancy rates appreciably. It is not a suitable treatment for women with egg or soy allergies